A. Kurchenko, Olha Mankivska, Kostiantyn Kurchenko, Halyna Fedoruk
{"title":"A RETROSPECTIVE ANALYSIS OF THE USE OF POSSIBLE DRUGS FOR THE PREVENTION AND TREATMENT OF COVID-19","authors":"A. Kurchenko, Olha Mankivska, Kostiantyn Kurchenko, Halyna Fedoruk","doi":"10.37321/immunology.2022.3-4-04","DOIUrl":null,"url":null,"abstract":"As the SARS-CoV-2 pandemic takes its toll, the urgent search for effective preventive and therapeutic drugs is rapidly accelerating. Currently, there are no proven effective methods of treating COVID-19. Most antiviral drugs have only in vitro data. Solidarity clinical trials, in which not only the search for new drugs for the treatment of COVID-19 is carried out, but also the mass screening of existing drugs (mainly antivirals) that already have permission for use for treatment or for clinical trials. However, despite the great importance of a therapeutic strategy against the disease, the main way to prevent the spread of the virus is to develop an effective and safe prophylaxis.","PeriodicalId":245566,"journal":{"name":"Immunology and Allergy: Science and Practice","volume":"36 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology and Allergy: Science and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37321/immunology.2022.3-4-04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
As the SARS-CoV-2 pandemic takes its toll, the urgent search for effective preventive and therapeutic drugs is rapidly accelerating. Currently, there are no proven effective methods of treating COVID-19. Most antiviral drugs have only in vitro data. Solidarity clinical trials, in which not only the search for new drugs for the treatment of COVID-19 is carried out, but also the mass screening of existing drugs (mainly antivirals) that already have permission for use for treatment or for clinical trials. However, despite the great importance of a therapeutic strategy against the disease, the main way to prevent the spread of the virus is to develop an effective and safe prophylaxis.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
